INTRODUCTION 1
inferred from studies using other animal caliciviruses that can grow in mammalian cell cultures. A 3 coterminal polyadenylated subgenomic RNA is produced within infected cells, and it is believed that both genomic and subgenomic RNAs are covalently linked to the nonstructural protein VPg at their 5 ends. Upon infection of cells, nonstructural proteins are expressed from genomic RNA and form a RNA replication complex, which generates new genomic RNA molecules as well as subgenomic RNAs encoding VP1 and VP2. After expression of the structural proteins from subgenomic RNA molecules, the capsid is assembled and viral RNA encapsidated prior to progeny release. Some of these features have been confirmed using recombinant systems to express the native NV genome in mammalian cells by using vaccinia virus expression systems (2, 25).
Studies with human volunteers have shown that some individuals are either repeatedly susceptible or resistant to NV infection (37) , and led to the identification of a genetically determined factor that predicts a person's susceptibility to infection and disease (19, 30) . Binding experiments using recombinant NV virus-like particles (VLPs) demonstrated attachment of VLPs to surface epithelial cells of the gastroduodenal junction on biopsies from secretor individuals, but not to cells from non-secretors, showing that the expression pattern of ABH histo-blood group antigens may influence susceptibility to NV (32). The gene responsible for the secretor phenotype encodes an (1,2)fucosyltransferase (FUT2) that produces H antigens on the surface of epithelial cells and in mucosal secretions (27) The main goal of our study was to understand the molecular basis of the restricted growth of NV in cultured cells by transfecting wildtype NV RNA into human cells.
Our studies show for the first time that transfection of wildtype NV RNA isolated from human stool samples can lead to the production of viral particles, indicating that wildtype NV RNA is infectious and replicates. However, a block of NV spread to other cells in the culture remains, indicating that the block(s) exist at the cell entry and/or uncoating steps.
MATERIALS AND METHODS
Cell lines and NV stool specimens. The human intestinal CaCo-2 cell line was obtained from the American Type Culture Collection, and was maintained in Earle's minimum essential medium (MEM) supplemented with 10% fetal bovine serum (FBS). The hepatic Huh-7 cell line was kindly provided by Dr S. Makino. Huh-7.5.1 cells were kindly provided by Dr F. Chisari (47) . Huh-7 and Huh-7.5.1 cells were maintained in Dulbecco's minimal essential medium (DMEM) supplemented with 10% FBS.
Stool specimens from human volunteers 715 (100521) and 722 (100619) experimentally infected with NV (Atmar, unpublished data, 35) were used throughout the study. NV titers of stool specimens were higher than 1x10 11 RNA genomic copies per gram. Antibodies and plasmids. Polyclonal hyperimmune antiserum to recombinant NV VLPs raised in rabbits and mouse monoclonal antibodies (mAb) NV3901 and NV8812 have been described elsewhere (16, 23, 36, 44) . Antiserum to VPg was made by hyperimmunizing rabbits with a his-tagged VPg expressed and purified in E.coli Bl-21 (DE3) cells. The BG-4 anti-H type 1 specific mAb was purchased from
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Signet Pathology Systems (Dedham, MA), the BRIC 231 anti-H type 2 mAb was purchased from Biogenesis (United Kingdom), and the anti-Le b mAb was purchased from Gamma Biologicals (Houston, TX).
An expression vector containing the human secretor blood group 
Detection of NV proteins in transfected cells by immunofluorescence analysis (IF).
At various hours post transfection (hpt), cells were rinsed once with 0.1 M PBS and fixed in 4% paraformaldehyde (PF) for 30 min at room temperature.
After incubating cells in 0.5% Triton X-100, 0.1 M PBS for 15 min at room temperature for permeabilization, cells were blocked at 37ºC for 2 h in 0.1 M PBS, 1% BSA. Primary antibodies were added to the wells at the appropriate dilution in 0.1 M PBS, 1% BSA (1:1,000 for rabbit anti-VPg, and 1:5,000 for mAbs NV3901
and NV8812) and incubated overnight at 4ºC. Cells were washed in 0.1 M PBS, and incubated for 2 h at room temperature in a 1:1,000 dilution of the corresponding secondary antibody conjugated to Alexa Fluor 594 or 488. Nuclei were stained with 300 nM DAPI for 15 min at room temperature. Following the final wash step, fluorescence was detected using an Olympus IX-70 inverted-system microscope. Standard curves for absolute RNA quantification were included in every assay and were generated by using RNA transcripts produced by in vitro transcription of a cDNA that contained both ORF1 and ORF2-targeted regions (nt 4,487-5,671).
Primers and probes used to amplify both regions have been previously described (2). Normalization versus GAPDH titers was performed using the TaqMan GAPDH Control Reagents (Human) (Applied Biosystems). Standard curves included 5 dilutions and 3 replicate wells for each dilution. All samples were quantified in at least duplicate wells. Reactions were performed using the TaqMan One-Step RT-PCR Master Mix Reagents Kit (Applied Biosystems) in a 7500 Real Time PCR System (Applied Biosystems). The thermal protocol consisted of 30 min at 48°C, followed by 10 min at 95°C, and 45 cycles of 15 sec at 95°C and 1 min at 60°C.
Analysis of intracellular RNA. Total cellular RNA was isolated from 1x10 5 cells using the RNeasy Mini Kit (Qiagen). Poly(A)+ RNA was further purified from total cellular RNA using the MicroPoly(A) Purist kit (Ambion) and analyzed by Northern blot and qRT-PCR using the same set of primers and probes described above. total RNA from each well was isolated using the RNeasy Mini Kit (Qiagen), and analyzed by qRT-PCR with NV ORF2 primers and GAPDH. The input virus was measured by adding equivalent amounts of virus to wells that had been incubated with PBS, 1% BSA alone just before purifying the RNA. Experiments were performed in duplicate wells, and the percentage of bound virus relative to the input virus was calculated after performing the ORF2/GAPDH ratio for each well.
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The ability of specific mAbs against VP1 to block binding was examined by preincubating the sample in PBS, 1% BSA with serial 10-fold dilutions of ascites fluids for 2 h at room temperature as previously described (44), prior to performing the binding assay as described above.
Infection of cultures.
Forty-eight hours after transfection of Huh-7 cells grown on 48-well plates with a plasmid encoding the FUT2 enzyme or the empty vector using
Lipofectamine 2000, cells were washed twice with serum-free media. The inocula containing wildtype NV isolated from stool diluted in serum-free media was left onto cells for 3 h at 37ºC, and was replaced with fresh media containing 10% FBS. Cells were fixed with PF at 24 h post-infection (hpi), and viral replication was analyzed by IF using the mAb NV8812 against VP1 protein.
Statistics. All statistical analyses were conducted using the Student's t-test in SigmaPlot 10.0. Error bars represent standard deviation and statistical significance was defined as p<0.01. Stools from two volunteers containing high titers of NV were used as a source of willdtype NV RNA. Virus was purified from 5 g-aliquots of stool by CsCl gradient centrifugation, and each fraction was suspended in a final volume of 100 µl of milli-Q water. The presence of VP1 antigen and NV RNA in each fraction was analyzed by ELISA (Fig. 1A ) and qRT-PCR (Fig. 1B) . The peak viral antigen and nucleic acid corresponded to fractions with CsCl densities of 1.37-1.39 g/ml, which is consistent with previous reports for noroviruses (22) . The presence of viral particles in these fractions was confirmed by electron microscopy (Fig. 1C ). NV RNA was purified from 15 µl of the peak fraction (F8), and the RNA integrity was assessed by Northern blot before transfection (Fig. 1D) , showing a major band of 7.7 kb corresponding to the size of NV genomic RNA.
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Transfection of wildtype NV RNA into CaCo-2 and Huh-7 cells leads to expression of viral antigens.
Since it is believed that the NV RNA 5 end is covalently linked to a VPg protein, proteinase K was not used to extract the RNA from NV particles purified from stool. A kinetic analysis of NV protein expression in Huh-7 showed that although clusters containing 4-6 positive cells were frequently observed by 2 days post-transfection (dpt), a significant increase in the percentage of positive cells over time was not detected, and morphological changes were observed by 4 dpt (Fig. 4A) .
Morphological changes observed in NV expressing cells are analyzed in more detail at higher magnification in Fig. 4B . Between 2-3 dpt, NV-transfected cells started to detach from the surface plate, and by 5 dpt the vast majority of NVtransfected cells showed dramatic cytopathic effects that resulted in cell lysis.
Altogether, these results suggest that cell-to-cell spread of virus resulting in infection of the complete cell monolayer did not occur. Next, to elucidate whether a complete cycle of viral replication occurred, we tested if different steps of the viral replication cycle, such as viral RNA replication, and assembly and release of progeny virus to the media could be observed.
Poly(A)-containing RNA produced in Huh-7 transfected cells at different times pt were examined by Northern blot analysis, using an anti-sense RNA probe specific for the NV ORF2 region, and qRT-PCR using primers targeting regions either in ORF1 or ORF2. While ORF2 primers are able to amplify both genomic and subgenomic RNAs, ORF1 primers will only amplify genomic RNA. By Northern blot, a band corresponding to positive sense subgenomic RNA was detected starting at 24 hpt. A clear band corresponding to genomic RNA could not be observed, probably due to the low number of NV-transfected cells and low sensitivity of Northern blots, especially to detect high-molecular weight bands ( and ORF2 primers began to be observed at 24 hpt, and was more obvious at 48 hpt (Fig. 5B ). Although at 0 hpt, the titer using ORF2 primers was approximately 3 times lower than the titer obtained with ORF1 primers, probably due to different primer sensitivities, a 9-fold and a 31-fold increase was observed from 0 h to 48 hpt for ORF1 and ORF2 primers, respectively, indicating that both genomic and subgenomic RNAs were being synthesized. Levels of GAPDH mRNA did not change. The higher fold increase detected with ORF2 primers indicated that subgenomic RNA was being synthesized and confirmed the results obtained by To determine whether viral particles were generated and released from cells, the presence of viral RNA and VP1 protein in the culture supernatant was confirmed by qRT-PCR and ELISA, respectively (Fig. 6A) . To rule out the detection of input or free viral RNA, culture supernatants were treated with RNAse A prior to extraction of RNA. Overall, a 3-log 10 increase in viral RNA was detected from 0 h to 96 hpt, reaching a titer of (1.4 ± 0.4) x 10 7 NV RNA copies/ml. A correlation was observed in the detection of viral protein by ELISA and RNA titer, and intact virions were detected by electron microscopy in samples concentrated by pelleting through a sucrose cushion (Fig. 6B) . Taking into account the number of positive cells showed that the VP1 protein of VLPs could be detected on the surface of cells (Fig.   8A ). Table 2 production by Huh-7.5.1 cells (Fig. 9 ), but the differences were not statistically significant. Similar levels of intracellular synthesized subgenomic RNA were detected by Northern blot between both cell lines (data not shown). These results demonstrate that NV RNA replication efficiency is similar between Huh-7 and Huh-7.5.1, and suggest that an inactivating mutation in RIG-I does not have any effect on NV RNA replication, and that RIG-I signaling pathway does not account for the block of NV infection in Huh-7 cells.
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DISCUSSION
The absence of a robust cell culture model for NV infection has limited the study of the NV life cycle, the development of effective antivirals and vaccines, and A recent report describing a reverse genetics system for murine noroviruses using a recombinant fowlpox virus expressing T7 RNA polymerase (9) showed no differences in virus recovery when using Huh-7.5.1 cells or Vero cells, which are defective for interferon production, suggesting that the interferon system does not play a role in the restriction of virus recovery.
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Our results show that NV replication is not enhanced in Huh-7.5. carbohydrates were used to detect carbohydrates, and DAPI was used for nuclear counterstaining. 
